Enhanced chromosomal response of ataxia-telangiectasia cells to specific types of DNA double-strand breaks.
The chromosomal response of two ataxia-telangiectasia (A-T) lymphoblastoid cell lines (A-T-PA and A-T-KM) to restriction endonucleases (RE) is compared with that of a normal (N-SW) lymphoblastoid cell line. The RE used were PvuII (generating DNA double-strand breaks with blunt termini), BamHI (cohesive termini with 4 base, 5' overhangs) and PstI (cohesive termini with 4 base 3' overhangs). Chromatid aberrations were analysed in cells 5 h after treatment. Cells were porated using streptolysin O to allow entry of RE. Both A-T lines showed an enhanced frequency of chromatid breaks in G2 phase compared with normal cells in response to RE. The enhanced response of A-T cells was most marked in the case of PvuII treatment when the enhancement ratios were 2.5 and 4.2 for A-T-PA and A-T-KM respectively. However, the frequency of DNA double-strand breaks (dsb), measured by neutral filter elution, were considerably lower in A-T-PA cells than N-SW, due to a lower efficiency of poration. When A-T-PA cells were treated with streptolysin O at a higher concentration (0.3 Units/ml), a condition that apparently led to a similar level of poration in A-T-PA as in N-SW cells treated with 0.06 Units/ml as judged by the similar number of dsb induced in the two lines for a given PvuII concentration, the enhancement ratio for A-T-PA cells treated with PvuII increased from 2.5 to 5.8. BamHI and PstI were found to be less clastogenic in all three cell lines as found previously for Chinese hamster cells, although part of this effect may be due to a lower activity, particularly in the case of PstI. However, even at a 4-6-fold higher concentration, BamHI was still less clastogenic than PvuII. It is concluded that dsb with blunt termini are more clastogenic than those with cohesive termini. The results suggest that the chromosomal sensitivity of A-T cells may result from a defect causing a higher rate of conversion of dsb into chromatid aberrations.
School of Biological and Medical Sciences, University of St Andrews, UK.
N
N
Liu
P E
PE
Bryant
D001260:Ataxia Telangiectasia / Q000235:genetics* / Q000473:pathology; D002460:Cell Line; D002842:Chromatids / Q000187:drug effects / Q000502:physiology; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000187:drug effects* / Q000502:physiology*; D004247:DNA / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*; D004249:DNA Damage; D004262:DNA Restriction Enzymes / Q000378:metabolism / Q000494:pharmacology*; D015257:DNA-Cytosine Methylases / Q000378:metabolism; D015252:Deoxyribonucleases, Type II Site-Specific / Q000378:metabolism; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000648:ultrastructure
D004247:DNA; C042525:DNA modification methylase BamHI; D015257:DNA-Cytosine Methylases; D004262:DNA Restriction Enzymes; C025630:CAGCTG-specific type II deoxyribonucleases; C024388:CTGCAG-specific type II deoxyribonucleases; D015252:Deoxyribonucleases, Type II Site-Specific